• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Qilian International Holding Group Ltd.

    10/22/24 4:15:15 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BGM alert in real time by email
    6-K 1 tm2426499d1_6k.htm FORM 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
    THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of October 2024

      

    Qilian International Holding Group Ltd.

     

    No. 152 Hongliang East 1st Street, No. 1703,

    Tianfu New District, Chengdu, 610200

    People’s Republic of China

    +86-028-64775180

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F x Form 40-F ¨

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

      

     

     

     

     

    Submission of Matters to a Vote of Security Holders.

     

    Qilian Internationl Holding Group Ltd. (the “Company”) held an extraordinary meeting of shareholders (the “EGM”) at 9:00 a.m. ET on October 18, 2024 at No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, PRC. Shareholders of the Company’s Class A ordinary shares (the “Class A Ordinary Shares”) and Class B ordinary shares (the “Class B Ordinary Shares”) voted by proxy or at the meeting. Holders of 3,398,092 out of a total of 4,826,480 Class A Ordinary Shares issued and outstanding, and holders of 2,400,000 out of a total of 2,400,000 Class B Ordinary Shares issued and outstanding voted at the EGM in person or by proxy. More than one-third (1/3) of the Class A Ordinary Shares and Class B Ordinary Shares, voting together as a single class, entitled to vote at the EGM are represented in person or by proxy, and a quorum for the transaction of business was present at the Meeting. Each Class A Ordinary Share is entitled to one vote and each Class B Ordinary Share is entitled to fifty (50) votes. The final voting results for each matter submitted to a vote of shareholders at the meeting are as follows:

     

    1.

    The following constitutes the number of votes voted with respect to the approval and ratification of the following share consolidation:

     

    (i) the consolidation of the Company’s authorized share capital, at a ratio of five-for-one, from US$833,335 divided into 350,000,000 class A ordinary shares of par value of US$0.00166667 each, 100,000,000 class B ordinary shares of par value of US$0.00166667 each, and 50,000,000 preferred shares of par value of US$0.00166667 each to US$833,335 divided into 70,000,000 class A ordinary shares of par value of US$0.00833335 each (the “Class A Ordinary Shares”), 20,000,000 class B ordinary shares of par value of US$0.00833335 each (the “Class B Ordinary Shares”, together with Class A Ordinary Shares, the “Ordinary Shares”) and 10,000,000 preferred shares of par value of US$0.00833335 each (the “Preferred Shares”) with effect from June 21, 2024;

     

    (ii) the consolidation of all the 23,750,000 issued class A ordinary shares of par value of US$0.00166667 each in the capital of the Company into 4,826,480 issued Class A Ordinary Shares (all fractional shares resulting from the consolidation were rounded up to the nearest whole number) and the consolidation of all the 12,000,000 issued class B ordinary shares of par value of US$0.00166667 each in the capital of the Company into 2,400,000 issued Class B Ordinary Shares with effect from June 21, 2024, and no change in the number of issued and outstanding Preferred Shares as no Preferred Shares are issued and outstanding; and

     

    (iii) the consolidation of the 326,250,000 authorized but unissued class A ordinary shares of par value of US$0.00166667 each in the capital of the Company into 65,173,520 authorized but unissued Class A Ordinary Shares (additional shares were issued as a result of the consolidation as all fractional shares were rounded up to the nearest whole number), 88,000,000 authorized but unissued class B ordinary shares of par value of US$0.00166667 each in the capital of the Company into 17,600,000 authorized but unissued Class B Ordinary Shares, and 50,000,000 authorized but unissued preferred shares of par value of US$0.00166667 each into 10,000,000 Preferred Share with effect from June 21, 2024;

      

    For   Against   Abstain
    123,491,278   17,451   4,975

     

    Accordingly, the Share Consolidation has been approved and ratified.

     

    2. The following constitutes the votes with respect to that the approval of theincrease of the authorized number of Class A Ordinary Shares of the Company to 5,000,000,000, with the Company’s authorized share capital to be increased accordingly from US$833,335 divided into 70,000,000 Class A Ordinary Shares, 20,000,000 Class B Ordinary Shares, and 10,000,000 Preferred shares to US$41,916,750.50, divided into 5,000,000,000 Class A Ordinary Shares, 20,000,000 Class B Ordinary Shares, and 10,000,000 Preferred Shares (the “Increase of Authorized Class A Ordinary Shares and Authorized Share Capital”);

     

     

     

     

    For   Against   Abstain
    123,408,039   8,716   252

     

    Accordingly, the Increase of Authorized Class A Ordinary Shares and Authorized Share Capital has been approved.

     

    3. The following constitutes the votes with respect to the approval of the change of Company’s name to BGM Group Ltd 博美集团有限公司 (the “Change of Name”);

     

    For   Against   Abstain
    123,501,614   6,606   5,485

     

    Accordingly, the Change of Name has been approved and adopted.

     

    4. The following constitutes the votes with respect to the approval of the following changes of the rights, respectively, that, (collectively, the “Changes of Rights”):

     

    (i) as as a special resolution of the holders of Class A Ordinary shares to approve no right of each of Class A Ordinary Shares to be converted into Class B Ordinary Shares and the increase of the voting rights attached to each Class B Ordinary Shares to one hundred (100) votes on any and all matters on a poll at any general meeting of the Company;

     

    For   Against   Abstain
    3,407,498   8,747   763

     

    (ii) as a special resolution of the holders of Class B Ordinary shares to approve the increase of the voting rights attached to each Class B Ordinary Share to one hundred (100) votes on any and all matters on a poll at any general meeting of the Company and that the Class B Ordinary Shares can only be issued to the directors of the Company, the holders of the existing shares in the Company’s share capital, or entities that are wholly owned by such directors of the Company or holders of the existing shares in the Company’s share capital.

     

    For   Against   Abstain
    120,000,000   0   0

     

    Accordingly, the Changes of Rights has been approved and adopted.

     

    5. The following constitutes the votes with respect to the approval that the second amended and restated memorandum of association of the Company adopted by a special resolution passed on April 19, 2024 and made effective on April 29, 2024  be amended and restated by the deletion in their entirety and by the substitution in their place of the third amended and restated memorandum and articles of association in the form as attached hereto as Appendix A (the “Amended M&AA”) to reflect, inter alias, the Share Consolidation, the Increase of Authorized Class A Ordinary Shares and Authorized Share Capital, the Change of Name, and the Changes of Rights to the extent each is effected;

     

     

     

     

    For   Against   Abstain
    123,408,044   8,712   252

     

    Accordingly, the Amended M&AA has been approved and adopted.

     

    6. As an ordinary resolution, to adjourn the Extraordinary Meeting to a later date or dates or sine die, if necessary, to permit further solicitation and vote of proxies if, at the time of the Extraordinary Meeting, there are not sufficient votes for, or otherwise in connection with, the approval of the foregoing proposals (the “Authorization to Adjourn the Meeting”).

     

    For   Against   Abstain
    123,489,001   19,692   5,012

     

    Accordingly, the Authorization to Adjourn the Meeting has been approved.

     

    The board of directors has unanimously approved that the effective date of the Share Consolidation, the Increase of Authorized Class A Ordinary Shares and Authorized Share Capital, the Change of Name, the Change of Rights and the Amended M&AA is October 18, 2024.

     

    Exhibit

     

    No.   Description
    1.1  Third Amended and Restated Memorandum and Articles of Associate, adopted and made effective on October 18, 2024.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Dated: October 22, 2024

     

      Qilian International Holding Group Ltd.
         
      By: /s/Chen Xin
      Name:  Chen Xin
      Title: Chief Executive Officer (Principal Executive Officer)

     

     

     

    Get the next $BGM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BGM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BGM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025

    CHENGDU, China, July 23, 2025 /PRNewswire/ -- BGM Group (the "Company" or "BGM") (NASDAQ:BGM) today announced that it will release its unaudited financial results for the first half 2025 before the U.S. financial markets open on July 24, 2025 Eastern Daylight Time. About BGM  BGM Group Ltd. has a strategic focus on the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. In terms of AI application implementation, the group relies on advanced analytics and AI Agent technology, and utilizes the two platforms of Du Xiao Bao and Bao Wang to provide comprehensive and professional AI solutions and intelligent robot services

    7/23/25 6:36:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts

    CHENGDU, China, May 28, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM)  (NASDAQ:BGM) today announced that it has entered into definitive transaction agreements with the existing shareholders of Xingdao Intelligent Cloud Chain (Shenzhen) Co., Ltd. ("Xingdao Intelligent") and YD Network Technology Company Limited ("YD Network"). Under the terms of the agreements, BGM will acquire 100% of the equity interests of both companies at a combined valuation of RMB800 million. The consideration will be paid through the issuance of 37,123,142 newly issued Class A ordinary shares of BGM at a price of US$3.0 per share. The transactions are expected to close by the end of June 2025, subject to

    5/28/25 4:30:00 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem

    CHENGDU, China, May 2, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) (the "Company" or "BGM") , a leading AI technology company, today announced it has entered into a definitive agreement (the "Agreement") to acquire HM Management Company Limited ("HM Management"), a prominent AI agent production platform, in an all-stock transaction valued at approximately RMB300 million (US$41.7 million). Under the Agreement, BGM will issue 16,663,427 Class A ordinary shares at $2.50 per share to acquire 100% ownership of HM Management and its two wholly-owned subsidiaries: Beijing Shuda Technology Company Limited. ("Shuda Technology") and New Media Star Technology (Shenzhen) Co., Ltd ( "New Media Star

    5/2/25 8:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BGM
    SEC Filings

    View All

    SEC Form NT 20-F filed by BGM Group Ltd.

    NT 20-F - BGM Group Ltd. (0001779578) (Filer)

    1/30/26 4:30:13 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by BGM Group Ltd.

    6-K - BGM Group Ltd. (0001779578) (Filer)

    1/29/26 8:27:49 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by BGM Group Ltd.

    6-K - BGM Group Ltd. (0001779578) (Filer)

    12/22/25 7:00:19 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BGM
    Leadership Updates

    Live Leadership Updates

    View All

    BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution

    CHENGDU, China, Feb. 28, 2025 /PRNewswire/ -- BGM Group Ltd (NASDAQ:BGM) (the "Company" or "BGM") today announced changes to its board of directors, marking the Company's entry into a new phase of technological transformation and sustainable growth. Mr. Zhanchang Xin has tendered his resignation and will step down from his role as Chairman of the Company, effective March 1, 2025. He will be succeeded by Mr. Chen Xin, the current Chief Executive Officer of the Company, who will assume the position of Chairman. As the founder of the Company, Mr. Zhanchang Xin has, over the past six decades, has played a pivotal role in leading the Company through numerous challenges and milestones, including

    2/28/25 8:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BGM Group Establishes "Duxiaobao Management Committee" to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry

    CHENGDU, China, Feb. 19, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the management and decision-making of the "Duxiaobao" ecosystem. This move signifies BGM Group's strategic entry into the field of artificial intelligence, aiming to accelerate the transformation of the insurance industry into the smart era through AI technology. The Duxiaobao Management Committee consists of industry leaders such as Xin Chen, Li Yuqing, Ge Peng, Zhao Qi, Ren Yong, Li Jun, Zhou Xin, and Wang Hui. The committee has appointed Li Yuqing as the CEO of Duxiaobao, with Li Jun, Ren Yong, Zhou Xin, and Tan

    2/19/25 7:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by BGM Group Ltd.

    SC 13D - BGM Group Ltd. (0001779578) (Subject)

    12/3/24 6:03:06 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by BGM Group Ltd.

    SC 13D/A - BGM Group Ltd. (0001779578) (Subject)

    11/29/24 9:00:27 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D filed by Qilian International Holding Group Ltd.

    SC 13D - Qilian International Holding Group Ltd (0001779578) (Subject)

    10/16/24 4:19:46 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BGM
    Financials

    Live finance-specific insights

    View All

    From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts

    CHENGDU, China, May 28, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM)  (NASDAQ:BGM) today announced that it has entered into definitive transaction agreements with the existing shareholders of Xingdao Intelligent Cloud Chain (Shenzhen) Co., Ltd. ("Xingdao Intelligent") and YD Network Technology Company Limited ("YD Network"). Under the terms of the agreements, BGM will acquire 100% of the equity interests of both companies at a combined valuation of RMB800 million. The consideration will be paid through the issuance of 37,123,142 newly issued Class A ordinary shares of BGM at a price of US$3.0 per share. The transactions are expected to close by the end of June 2025, subject to

    5/28/25 4:30:00 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

    CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordinary shares at a price of $2 per share, for a total transaction valuation of RMB550 million. The transaction is expected to be completed in the second quarter of 2025. Wonder Dragon possesses over 3,000 metric tons of premium Qingzhuan dark tea inventory, comprising 1,670 metric tons of raw materials and 1,350 metric tons of finished products. These premium tea products, known f

    4/21/25 8:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform

    CHENGDU, China, March 19, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM) (NASDAQ:BGM) today announced that it has signed a definitive agreement with the existing shareholders of YX Management Company Ltd. ("YX"), a smart mobility technology company. Under the agreement, BGM will acquire 100% of the equity interests of YX by issuing 47.5 million class A ordinary shares to its existing shareholders, valuing YX at US$95.0 million. This acquisition is based on the exceptional expertise and experience of the YX team in scalable operations, digital infrastructure development, and technology commercialization. The integration of this team will accelerate the AI-driven strategic upgrade

    3/19/25 8:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care